111 related articles for article (PubMed ID: 11747451)
21. Identification of a key region of kinin B(1) receptor for high affinity binding of peptide antagonists.
Bastian S; Pruneau D; Loillier B; Robert C; Bonnafous JC; Paquet JL
J Biol Chem; 2000 Mar; 275(9):6107-13. PubMed ID: 10692400
[TBL] [Abstract][Full Text] [Related]
22. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
[TBL] [Abstract][Full Text] [Related]
23. Spontaneous human B2 bradykinin receptor activity determines the action of partial agonists as agonists or inverse agonists. Effect of basal desensitization.
Fathy DB; Leeb T; Mathis SA; Leeb-Lundberg LM
J Biol Chem; 1999 Oct; 274(42):29603-6. PubMed ID: 10514427
[TBL] [Abstract][Full Text] [Related]
24. Differential pharmacology of cloned human and mouse B2 bradykinin receptors.
Hess JF; Borkowski JA; Macneil T; Stonesifer GY; Fraher J; Strader CD; Ransom RW
Mol Pharmacol; 1994 Jan; 45(1):1-8. PubMed ID: 8302267
[TBL] [Abstract][Full Text] [Related]
25. Cloning, sequencing and functional expression of a guinea pig lung bradykinin B2 receptor.
Farmer SG; Powell SJ; Wilkins DE; Graham A
Eur J Pharmacol; 1998 Apr; 346(2-3):291-8. PubMed ID: 9652372
[TBL] [Abstract][Full Text] [Related]
26. Identification of a B2 bradykinin receptor expressed by PC12 pheochromocytoma cells.
Nardone J; Gerald C; Rimawi L; Song L; Hogan PG
Proc Natl Acad Sci U S A; 1994 May; 91(10):4412-6. PubMed ID: 8183922
[TBL] [Abstract][Full Text] [Related]
27. Determination of bradykinin B2 receptor in vivo phosphorylation sites and their role in receptor function.
Blaukat A; Pizard A; Breit A; Wernstedt C; Alhenc-Gelas F; Muller-Esterl W; Dikic I
J Biol Chem; 2001 Nov; 276(44):40431-40. PubMed ID: 11517230
[TBL] [Abstract][Full Text] [Related]
28. Antagonist-induced intracellular sequestration of rabbit bradykinin B(2) receptor.
Houle S; Larrivée JF; Bachvarova M; Bouthillier J; Bachvarov DR; Marceau F
Hypertension; 2000 Jun; 35(6):1319-25. PubMed ID: 10856284
[TBL] [Abstract][Full Text] [Related]
29. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
Cucchi P; Meini S; Bressan A; Catalani C; Bellucci F; Santicioli P; Lecci A; Faiella A; Rotondaro L; Giuliani S; Giolitti A; Quartara L; Maggi CA
Eur J Pharmacol; 2005 Dec; 528(1-3):7-16. PubMed ID: 16324696
[TBL] [Abstract][Full Text] [Related]
30. Site-directed mutagenesis at the human B2 receptor and molecular modelling to define the pharmacophore of non-peptide bradykinin receptor antagonists.
Meini S; Cucchi P; Bellucci F; Catalani C; Faiella A; Rotondaro L; Quartara L; Giolitti A; Maggi CA
Biochem Pharmacol; 2004 Feb; 67(4):601-9. PubMed ID: 14757160
[TBL] [Abstract][Full Text] [Related]
31. Human and rat bradykinin B2 receptors are differentially sensitive to D-Phe7-containing antagonists.
Davis CL; Phillips E; Skidmore E; Webb M; McIntyre P; Burgess GM
Biochem Soc Trans; 1995 Feb; 23(1):97S. PubMed ID: 7758817
[No Abstract] [Full Text] [Related]
32. Intramolecular signal transduction by the bradykinin B2 receptor.
Mueller S; Liebmann C; Reissmann S
Int Immunopharmacol; 2002 Dec; 2(13-14):1763-70. PubMed ID: 12489790
[TBL] [Abstract][Full Text] [Related]
33. Receptor phosphorylation does not mediate cross talk between muscarinic M(3) and bradykinin B(2) receptors.
Willars GB; Müller-Esterl W; Nahorski SR
Am J Physiol; 1999 Nov; 277(5):C859-69. PubMed ID: 10564078
[TBL] [Abstract][Full Text] [Related]
34. Ligand-induced phosphorylation/dephosphorylation of the endogenous bradykinin B2 receptor from human fibroblasts.
Blaukat A; Alla SA; Lohse MJ; Müller-Esterl W
J Biol Chem; 1996 Dec; 271(50):32366-74. PubMed ID: 8943300
[TBL] [Abstract][Full Text] [Related]
35. Aspirin inhibits human bradykinin B2 receptor ligand binding function.
Gardes J; Michineau S; Pizard A; Alhenc-Gelas F; Rajerison RM
Biochem Pharmacol; 2008 May; 75(9):1807-16. PubMed ID: 18355801
[TBL] [Abstract][Full Text] [Related]
36. Structure of the bradykinin B2 receptors' amino terminus.
AbdAlla S; Godovac-Zimmermann J; Braun A; Roscher AA; Müller-Esterl W; Quitterer U
Biochemistry; 1996 Jun; 35(23):7514-9. PubMed ID: 8652530
[TBL] [Abstract][Full Text] [Related]
37. Tissue kallikrein actions at the rabbit natural or recombinant kinin B2 receptors.
Houle S; Molinaro G; Adam A; Marceau F
Hypertension; 2003 Mar; 41(3):611-7. PubMed ID: 12623967
[TBL] [Abstract][Full Text] [Related]
38. Cloning and pharmacological characterization of the rabbit bradykinin B2 receptor.
Bachvarov DR; Saint-Jacques E; Larrivée JF; Levesque L; Rioux F; Drapeau G; Marceau F
J Pharmacol Exp Ther; 1995 Dec; 275(3):1623-30. PubMed ID: 8531137
[TBL] [Abstract][Full Text] [Related]
39. Interaction of linear and cyclic peptide antagonists at the human B(2) kinin receptor.
Cucchi P; Meini S; Quartara L; Giolitti A; Zappitelli S; Rotondaro L; Maggi CA
Peptides; 2002 Aug; 23(8):1457-63. PubMed ID: 12182947
[TBL] [Abstract][Full Text] [Related]
40. Hypotension in transgenic mice overexpressing human bradykinin B2 receptor.
Wang DZ; Chao L; Chao J
Hypertension; 1997 Jan; 29(1 Pt 2):488-93. PubMed ID: 9039147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
